1) On physical examination, pertinent findings included pale conjunctival mucosa and mild abdominal distention with hepatosplenomegaly. There was also mild tenderness in the right upper quadrant. In addition, the patient had gynecomastia. Genital examination revealed moderate bilateral scrotal swelling that transilluminated. The testicles were normal in size. We observed no penile discharge or erythema.
Abdominal ultrasound examination revealed cirrhosis of and nodes within the liver, diffuse thickening of the gallbladder with no gallstones, a small amount of ascites, left renal enlargement, and splenomegaly. Computed tomography (CT) of the abdomen revealed moderate ascites, marked bilateral hydroceles, pronounced cirrhosis of the liver with numerous nodules, and left periaortic lymphadenopathy (Image 1). The spleen was enlarged to 1.7 cm in diameter. These findings did not rule out an underlying neoplastic process. CT of the chest revealed a small right-sided basilar effusion and gynecomastia.
Ultrasound examination of the testis (Image 2) showed large bilateral loculated fluid collections within the scrotum, which resulted in lowering of both testicles. The fluid surrounding the right testicle measured 9 × 7 × 5 cm; the fluid surrounding the left testicle measured 12 × 7 × 8 cm. The fluid collections contained low-level internal echoes without septation or solid components. The testes had normal contour and homogeneous echo texture. We observed no intratesticular masses or calcifications. Blood-flow velocity, measured by Doppler ultrasound, was normal and symmetrical. The epididymis had a normal appearance and varicocele was not present. Scrotal thickness and appearance were normal. There was no evidence of an extra testicular mass or hernia.
Image 1
Computed tomography (CT) scan of the abdomen of a 20-yearold African American man, showing hepatosplenomegaly with nodular cirrhosis.
Image 2
Computed tomography scan of the underside of the testicles of a 20-year-old African American man. This sagittal section shows fluid pushing the testicles into an inferior position. The right testicle measured 3.8 × 2.1 × 2.3 cm; the left testis, 3.8 × 2.4 × 2.7 cm. We observed portal bridging fibrosis with chronic inflammation.
Hematological assessment revealed pancytopenia with a low hemoglobin count of 11.6 g/dL; platelets, 13 x 10 3 /mL; and white blood cell count, 1.5 x 10,000/mL with an absolute neutrophil count of 1.01/mL ( Table 1) . Other abnormal laboratory results included elevated immunoglobulin G (IgG, 2223 mg/dL), anti-smooth muscle antibody (86 U), D-dimer (>4000 ng/mL), alanine transaminase (81 U), aspartate transaminase (60 U), alkaline phosphatase (194 U), total bilirubin (16.23 mg/dL), and direct bilirubin (12.95 mg/ dL). The patient had a decreased haptoglobulin level of <10 mg/dL and total iron binding capacity (235 mg/dL); total iron was normal (67 mg/dL).
Cirrhosis of the Liver
2) Cirrhosis is often a silent disease process in which patients are asymptomatic until metabolic decompensation occurs. Cirrhosis may be caused by alcoholic liver disease, Hepatitis B and C Virus (HBV, HBC) infection, nonalcoholic hepatic steatosis, primary biliary cirrhosis, primary biliary cholangitis, autoimmune hepatitis, hereditary hemochromatosis, Wilson disease, and α-1 antitrypsin deficiency. Liver cirrhosis is confirmed by biopsy results.
The exposure threshold for hepatotoxicity is approximately 40 g of ethanol daily in men and 20 to 30 g in women. 1 The 3 stages of alcohol-induced liver disease are fatty liver, alcohol hepatitis, and liver cirrhosis; liver damage primarily results from ethanol metabolism, which produces acetaldehyde, NADH (reduced form of nicotinamide adenine dinucleotide), and reactive oxygen species. 2 In liver cirrhosis secondary to ethanol abuse, the ratio of aspartate transaminase (AST) to alanine transaminase (ALT) activity usually exceeds 2. The lower ALT activity in alcoholics is likely due to decreased pyridoxal 5′-phosphate, a cofactor for ALT. Our patient did not have a history of ethanol use.
HBV and HCV infection can cause cirrhosis of the liver. The acute phases of HBV or HCV infections cause lethargy, RUQ pain, jaundice, and anorexia; ALT activity in the serum is typically greater than AST activity. Patients with HBV infection who have cleared the antigen have a good prognosis; however, this does not completely eliminate their risk developing hepatocellular carcinoma.
3 Studies [4] [5] [6] [7] have shown that the mean time for cirrhosis to develop after exposure to HBV is 20 to 30 years. In chronic HCV infection, the AST and ALT activities are normal in one third of the patients. 6, 7 The remainder of the patients have a slightly raised activities of these enzymes. AST and ALT activities do not correlate with the histologic findings in HBV and HCV associated cirrhosis of the liver. 8, 9 In our patient, serum HBV and HCV assay results were negative, Non-alcoholic hepatic steatosis resembles alcoholic liver disease but occurs in patients who do not abuse ethanol. Patients with this disease usually have a history of dyslipidemia, obesity, and type 2 diabetes. Cirrhosis may result after years of subclinical progression of the inflammatory and fibrotic processes. 10 Primary biliary cirrhosis (PBC) is a chronic progressive disease of the intrahepatic bile ducts that can lead to cirrhosis of the liver; the female to male ratio of PBC is 10:1. PBC is typically seen in middle aged women. Symptoms include fatigue, pruritis, and abdominal pain, and 40% of patients are asymptomatic, while 30% to 50% have hepatosplenomegaly and 15% present with splenomegaly. 11 Kita et al 1 proposed that the condition was autoimmune, with an error in expression of the major histocompatibility complex class 2 molecule on the duct epithelium that leads to accumulation of auto-reactive T cells around the bile duct. The final clinical picture of PBC is indistinguishable from cirrhosis caused by other disease processes. Antimitochondrial antibodies are typically found in 90% to 95% of patients with PBC; in our patient the level of these antibodies was not elevated (2.5 U) ( Table 2) . As a result, PBC was an unlikely diagnosis for our patient.
Primary sclerosing cholangitis (PSC) is characterized by the extensive inflammation and obliterative fibrosis of intrahepatic and extrahepatic bile ducts. 10 PSC is a cholestatic liver disease 12 that is highly associated with inflammatory bowel disease, particularly ulcerative colitis. A recent study 13 suggests that genetically predisposed autoimmunity is the most likely underlying mechanism for PSC. The mechanism appears to involve the secretion of inflammatory cytokines by activated macrophages, leading to infiltration of the stromal cells and bile duct with T lymphocytes. 10 The initial trigger has not been identified.
14 PSC usually leads to biliary cirrhosis, portal hypertension, and hepatic failure. 14 In contrast to PBC, autoantibodies are found in less than 10% patients with PSC. 10 The diagnosis of PSC is usually based on the clinical picture and histological findings: the bile ducts are inflamed and have concentric periductal or onion-skin fibrosis. 10 The histologic findings in our patient showed bile-duct proliferation with bridging fibrosis.
Autoimmune hepatitis (AIH) is difficult to differentiate from other chronic hepatic inflammatory diseases. It has been estimated that 78% of AIH cases occur in young and premenopausal women. 10 A serologic study 15 showed that AIH has 2 clinical types that are similar but genetically different: type 1 is similar to other non-organ specific multisystem diseases, whereas type 2 is more similar to organ-specific disease. Type 1 AIH usually exhibits antinuclear antibodies or anti-smooth muscle antibodies, whereas type 2 AIH exhibits antibodies against liver and/ or kidney microsomes. Initially, subclassification of AIH was thought to be irrelevant; however, recent evidence 16 has shown that patients with type 2 AIH have a poorer outcome than those with type 1 AIH. Without treatment, as many as 40% of patients will die within 6 months of diagnosis. 10 In our patient, AIH was one of the main differential diagnoses; we performed immunological tests and biopsies in an attempt to rule out AIH.
Other causes of cirrhosis of the liver include hemochromatosis and Wilson disease. Hemochromatosis results from excessive accumulation of iron in the body; this excess iron deposits itself in the intraparenchymal tissues. Hereditary hemochromatosis is caused by a mutation in the human hemochromatosis gene (HFE; C282Y/C282Y homozygous or C282Y/H63D compound heterozygous), which encodes for an HLA class I-like molecule that regulates intestinal absorption of dietary iron. 17 Iron causes injury to the tissues via peroxidation and release of oxygen-reactive species. In our patient, the iron and transferrin levels were normal; thus we ruled out the diagnosis of hemochromatosis.
Wilson disease is an autosomal recessive disorder marked by accumulation of toxic levels of copper in multiple tissues; it may appear like hepatitis, cirrhosis, or hepatic decompensation. The defect in Wilson disease is in the gene ATP7B, which codes for a copper-transporting ATPase in the hepatocyte membrane. 18 A defect in the ATPase prevents the excretion of copper, which leads to accumulation and toxic injury to the liver. Wilson disease is ordinarily diagnosed via liver biopsy and quantitative copper assays. Affected patients have copper concentrations greater than 200 µg/g of liver tissue (dry weight). 19 In our patient, copper in the biopsy specimen was 60 μg/g ( Table 3 ); we thereby ruled out Wilson disease as the causative factor of the cirrhosis of the liver experienced by our patient. Although the value of 60 μg/g is higher than the reference range of 10 to 35 μg/g dry weight, such a mild elevated value is consistent with underlying cholestatic liver disease such as PBC, PSC, AIH and familial cholestatic syndrome. (Table 5) , and hemoglobin A1 and A2 (Table 6) , were all normal ( Table 3 and Table 4 ).
Scrotal Swelling
The differential diagnoses for scrotal swelling include testicular torsion, epididymitis, hydrocele, inguinal hernia, postoperative complication, and infection. The most common causes of scrotal pain and discomfort in adults are torsion and epididymitis. Testicular torsion can occur at any age. 21 In adults who experience scrotal pain, the prevalence of testicular torsion is 25% to 50%. 21, 22 On examination, our patient had an intact cremaster reflex, which is inhibited in testicular torsion; the cremaster reflex differentiates between torsion and epididymitis. 2 Results of the ultrasound examination performed on this patient showed a normal vascular flow; this makes torsion an unlikely diagnosis.
In acute infectious epididymis, the clinical presentation is dysuria or urethral discharge. The Prehn test (performed by elevating the scrotum) will relieve pain in patients with epididymitis; however, in those with torsion, this action might aggravate the condition or have no effect. 23 The Prehn test should be used along with other modalities, such as urinalysis, ultrasound, and the clinical picture, to narrow the differential diagnosis. 23, 24 Our patient did not have dysuria or penile discharge, and he was at low risk for sexually transmitted diseases. According to a study conducted by Liang and Pang 25 in patients with chronic epididymitis, 92.1% had epididymal swelling with tenderness and 75.5% had scrotal pain. These symptoms were not present in our patient; hence, we ruled out chronic epididymitis.
Two cases 26, 27 have been reported of tuberculosis of the testis that caused scrotal swelling. The clinical findings were usually of a hard testicle with negative results via transillumination. Hydrocele is a collection of the peritoneal fluid between the parietal and visceral layers of the tunica vaginalis. A communicating hydrocele increases in size during the day and decreases in size during the night. Communicating hydrocele is usually reducible; it is caused by a patent process vaginalis (embryonic developmental outpouching of the peritoneum). The scrotal swelling in our patient was the same size at all times; this suggests a noncommunicating hydrocele.
A noncommunicating hydrocele may be caused by trauma, tumors, epididymitis, or idiopathic causes. Our patient had no history of trauma. Testicular tumors are common in the age group of 15 to 35 years, and are the most common type of solid tumor, comprising 20% of all tumors in this age group. [28] [29] [30] Our patient had normal-sized testicles, the intraluminal space of the scrotum was full, with positive translucency. Therefore, a primary testicular tumor was unlikely in our patient.
Secondary tumors that cause malignant scrotal effusions have been reported; 25 however, given the ultrasound results in our patient, which did not show any varicocele, dilation of the pampiniform plexus, or tumors, the likely cause of hydrocele in our patient is idiopathic.
Pancytopenia
Pancytopenia is a relatively common hematological disorder in which red blood cells (RBCs), white blood cells (WBCs), and platelets are all decreased. 31 It is not a disease entity but a triad of findings that may result from a number of disease processes that primarily or secondarily involve the bone marrow. 32 The severity of pancytopenia and the underlying pathologic manifestations determine the management and prognosis of the patients. 33 Thus, identification of the correct cause will direct appropriate therapeutic measures.
Pancytopenia can be idiopathic or caused by secondary causes, such as leukemia, tumors, enzyme deficiencies, infections, vitamin deficiency, heavy metal poisoning, and/ or congenital syndromes. A bone marrow biopsy is usually required to determine the cause.
Bone marrow biopsy results for our patient showed trilineage cells; also the B12 and folate levels were normal. Therefore, the likely cause of pancytopenia in this patient was extravascular hemolysis secondary to sequestration in the lymphoreticular system of the spleen. We did not perform a direct Coombs test.
Gynecomastia
Gynecomastia is the benign proliferation of glandular breast tissue of greater than 4 cm in diameter in males; 19 it is most commonly observed in children and adolescents. The causes of gynecomastia include puberty, drugs, testicular tumors, hypogonadism, chronic renal failure, and cirrhosis of the liver. Given the normal testicular ultrasound results for our patient and his welldeveloped secondary sexual characteristics and normal renal functions, the likely cause of gynecomastia in our patient is cirrhosis of the liver, secondary to diminished catabolism of androstenedione the accumulated estrogen precursors are are converted to estrogen by peripheral aromatase activity. 19 This produces an increased estrogen to androgen ratio, that results in gynecomastia.
3) The diagnosis of AIH is consistent with the clinical presentation, along with laboratory, radiologic, and histopathologic results. Diagnosis of patients as having AIH is based on detection of autoantibodies, IgG levels, liver histologic findings, and the exclusion of viral hepatitis. 34 The histologic hallmark of AIH is a lymphoplasmacytic periportal infiltrate that invades the limiting plate, a process also known as piecemeal necrosis or interface hepatitis; this condition eventually progresses to lobular hepatitis.
In our patient, the IgG concentration was more than 1.5-fold the upper limit of normal, the smooth-muscle antibody results were positive, the antimitochondrial antibody results were negative, and the serologic markers of HBV and HCV were absent in the serum. 35 Histologically, we observed chronic inflammation10 and biliary-tract inflammation with bile-duct proliferation; approximately 25% of individuals with AIH have bile-duct proliferation. We also observed portal bridging fibrosis with chronic inflammation predominantly composed of lymphocyte infiltration around the peri-portal areas (Image 2, Image 3, Image 4).
Combining the clinical, laboratory, and histologic results, we reached the diagnosis of AIH.
4) The pathogenesis of AIH has not been fully elucidated; however, evidence suggests that genetic and environmental factors cause susceptibility to an unknown trigger, activating an immune response that results in liver damage.
Genetics
Although the mode of inheritance is unknown, AIH is associated with major histocompatibility complex (MHC), and the human leukocyte antigen (HLA), which activates the adaptive immune response via an antigenic peptide to T cells. Evidence 36, 37 has linked AIH with the HLA class II DRB1 alleles. The environmental interplay is apparent in the link between AIH and different alleles in different populations. AIH 1 in Europe and North America has been associated 37, 38 with the specific alleles DRB1*0301 and DRB1*0401. In Japan, Argentina, and Mexico, AIH 1 has been associated 39 with the alleles DRB1*0405 and DRB1*0404. Evidence 40 also suggests an increased risk for AIH associated with DQ2 in Latin America and a protective effect associated with DR5 and DQ3. HLA alleles have also been implicated 41 in genetic susceptibility to AIH 2, specifically HLA DR7 (DRB1*0701 allele) and HLA DR3 (DRB1*0301 allele).
Additional genes within the HLA locus, including immunoglobulin A and complement factor 4A, are related to AIH; patients with AIH frequently have immunoglobulin A (IgA) deficiency and low levels of C4A. [42] [43] [44] Evidence 45-47 also suggests that further genetic links exist outside the MHC complex; these links impart increased susceptibility in certain populations but have also been shown to influence disease progression, clinical manifestations, response to treatment, and prognosis. These links include an adenine-to-guanine substitution in the cytotoxic T-lymphocyte antigen 4, 45 polymorphisms in the tumor necrosis factor-α promoter region, polymorphisms in the fatty acid synthetase gene promoter, 46 and polymorphisms in the vitamin D receptor. 47 These associations were influenced by geography and ethnicity and were not present in all populations.
48,49

Molecular Mimicry
Although many genes have been linked to IAH, the exact trigger remains unclear. Some evidence [50] [51] [52] indicates a molecular mimic that involves chronic HBV or HCV: 50% of patients with IAH who have these conditions develop anti-nuclear or anti-smooth muscle autoantibodies, and 10% of patients with chronic HCV have antibodies to liver and kidney microsomes. There is homology between the HCV antigen and the target for anti-LKM-1 antibodies, namely, CYP2D6. 53, 54 Other suggestive triggers include links to CMV and herpes. Although sometimes classified separately, drug-induced AIH is caused by nitrofurantoin, minocycline, statins, and the anti-TNF agents adalimumab and infliximab. 
Image 4
Trichrome (magnification, ×10) that further accentuates the bridging fibrosis in the liver biopsy of a 20-year-old African American man.
Image 3
Hematoxylin-eosin stain (magnification, ×4) showing bile-duct proliferation and bridging fibrosis, in the liver biopsy of a 20-yearold African American man.
Immune System Dysfunction
The unknown trigger causes HLA class 2-antigen presentation, activation of the adaptive immune response, and T-cell activation. 56 In a healthy individual, this response includes activation of regulatory T cells that suppress the response and prevent liver damage. T-cells in patients with AIH are functionally impaired. Patients with AIH have lower numbers of CD4 + CD25
+ T-cells, and they express lower levels of the FOXP3 protein. [57] [58] [59] Regulatory T-cells in AIH have diminished function and do not effectively inhibit the immune response; 57, 58, 60 they specifically fail to inhibit interferon-γ production by CD4 and CD8 T cells. Instead, dysfunctional T-cells activate monocytes that contribute to the autoimmune response.61 Decreased amounts of natural killer Tcells are also linked to AIH, correlating with active disease and a return to more normal values occurring during druginduced remission. 59 These cells are also functionally impaired, producing less of the regulatory cytokine interleukin 4. 60 
Mechanism of Liver Damage
Once an antigen-presenting cell (APC) presents the initial antigen to a CD4-positive T helper cell in the presence of co-stimulatory signals, the T cells differentiate and produce cytokines; this initiates an immune response. The innate and the adaptive immune responses are activated, causing a massive influx of inflammatory infiltrate and causing the liver damage that is characteristic of AIH. 62 Liver destruction is caused by the interaction of autoantibodies bound to the surface hepatocytes with cytotoxic T-lymphocytes, cytokines released by T-helper 1 cells, monocytes (macrophages), activated complement proteins, and natural killer (NK) cells. 63 5) AIH is a relatively uncommon disorder that was first described in 1950 by Waldenstrom 64 as a chronic form of hepatitis in young women. In 1965, Mackay et al 9 coined the term "autoimmune hepatitis." The disorder has been known by a variety of terms, including active chronic hepatitis, chronic active hepatitis, autoimmune chronic active hepatitis, chronic aggressive hepatitis, lupoid hepatitis, and plasma cell hepatitis. In 1994, the International Autoimmune Hepatitis Group designated autoimmune hepatitis as the most accurate and suitable term for the condition. 65 
Image 5
Creatine kinase (CK) 19 (magnification, ×10) present in the biliary tracts, highlighting the bile-duct proliferation, in the liver biopsy of a 20-year-old African American man.
Image 6
Hematoxylin-eosin stain (magnification, ×4) shows portal-toportal bridging fibrosis with chronic inflammation predominantly made up of lymphocytes, in the liver biopsy of a 20-year-old African American man
Most of the data on AIH were collected before the introduction of the first International Autoimmune Hepatitis Group scoring system; therefore, diagnostic criteria were not standardized. Based on limited epidemiologic data, the prevalence of IAH is estimated at between 50 and 200 per 1 million white individuals in Western Europe and North America. In the North American and western European white populations, AIH accounts for approximately 20% of all cases of chronic hepatitis.
The incidence and characteristics of AIH differ in various geographic regions. Although the condition typically affects young and middle-aged women, it can occur in both sexes and across all age groups. AIH affects women 3.6-fold more commonly than men. 67 The incidence of type 1 AIH among white populations in Europe and North America ranges from 0.1 to 1.9 cases per 100,000 individuals per year; the disease is considerably less common in Japan. 66 People of all ethnicities are susceptible to the disease; however, the prevalence is greatest among people with northern European ancestry who have a high frequency of HLA-Drelated 3 and HLA-D-related 4 markers. The relative proportion of AIH among individuals with chronic hepatitis is low in regions with a high prevalence of viral hepatitis.
Type 2 AIH occurs more frequently in southern Europe compared with northern Europe, the United States, and Japan; it occurs most commonly in young adults and children. Type I AIH is more common in the United States and northern Europe. The ratio of incidence of type 1 AIH to type 2 AIH is 1.5 to 2:1 in Europe and Canada, and 6.0 to 7:1 in North America, South America, and Japan. AIH accounts for approximately 3% of liver transplantations in Europe and 6% in the United States. In Norway, the annual incidence was reported to be 1.9 cases per 100,000 individuals, with a prevalence of 17 cases per 100,000. In the United States, an annual incidence of 1 per 200,000 was reported. A Spanish report shows similar findings, with an annual incidence of 0.8 cases per 100,000 and a prevalence of 11.6 cases per 100,000,
Image 7
Trichrome (magnification, ×4) that further highlights the bridging fibrosis in the liver biopsy of a 20-year-old African American man
Image 8
Reticulin stain (magnification, ×10) that highlights the architectural distortion in the liver biopsy of a 20-year-old African American man.
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Case Studies leading to an estimated point prevalence of 10 to 15 cases per 100,000. 67 The reported prevalence of AIH in Japan is only 0.08 to 0.015 cases per 100,000. Among Asians and Hispanics, the latter group had the higher prevalence of cirrhosis; however, Asians had poorer survival outcomes.
6) Corticosteroids are the mainstay of AIH treatment; approximately 80% of recipients respond to this type of therapy. 19 Although corticosteroid therapy does not prevent the ultimate progression to cirrhosis, it can prolong the time before liver transplantation becomes necessary. Our patient had already developed cirrhosis of the liver, as have approximately 25% of patients with AIH at the time of diagnosis. AIH is associated with other autoimmune diseases such as celiac disease, ulcerative colitis, and autoimmune thyroid disease. A treatment regimen of prednisone, 60 mg daily tapered to 20 mg daily in 4 weeks, or at a lower dose of 30 mg daily tapered to 10 mg daily in 4 weeks, in combination with azathioprine (50 mg daily), is maximally effective. 68 The advantage of the combination approach is a reduction, over the span of 18 months, of life-threatening complications of corticosteroid therapy from 66% to 20%. 19 Treatment is usually maintained for at least 2 years.
Our patient has been hospitalized at least 3 times for supportive treatment since his diagnosis; his name was also placed on the liver-transplant list. He underwent paracentesis of the abdomen to relieve ascites and spontaneous bacterial peritonitis was ruled out. The supportive treatment for the patient included intravenous (IV) fluids and transfusion with packed RBCs, platelets and fresh frozen plasma. The patient underwent liver transplantation. Histologic images from the explant slides are demonstrated in Image 5, Image 6, Image 7, and Image 8. His symptoms of ascites have improved; currently a hepatologist is monitoring his condition. LM
